(+)-catechin multiple interactions EXP 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA CTD PMID:25663641 (+)-epicatechin-3-O-gallate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA CTD PMID:25663641 (+)-Tetrandrine increases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased susceptibility to tetrandrine CTD PMID:26302866 (+)-Tetrandrine increases glutathionylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased glutathionylation of tetrandrine CTD PMID:21992520 (+)-Tetrandrine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein promotes the reaction [tetrandrine results in decreased abundance of Glutathione] more ... CTD PMID:26302866 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA CTD PMID:25663641 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP3A13 mRNA CTD PMID:36331819 (2,4,5-trichlorophenoxy)acetic acid increases expression ISO CYP3A7 (Homo sapiens) 6480464 2 more ... CTD PMID:8812189 (E)-thiamethoxam increases expression ISO CYP3A7 (Homo sapiens) 6480464 Thiamethoxam results in increased expression of CYP3A7 CTD PMID:28750898 (E)-thiamethoxam multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Estriol inhibits the reaction [Thiamethoxam results in increased expression of CYP3A7] CTD PMID:28750898 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of CYP3A13 mRNA and alpha-Tocopherol results in increased expression of CYP3A13 protein CTD PMID:26102010 (R,R,R)-alpha-tocopherol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 alpha-Tocopherol inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone] CTD PMID:31102695 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of 1 more ... CTD PMID:12167570 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO CYP3A7 (Homo sapiens) 6480464 o and p'-DDT results in increased expression of CYP3A11 mRNA CTD PMID:17035600 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of CYP3A13 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP3A13 mRNA CTD PMID:22206623 1,4-naphthoquinone increases abundance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1,4-naphthoquinone increases abundance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1,8-cineole increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Eucalyptol CTD PMID:15715982 1-hydroxymidazolam multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam and erdafitinib inhibits the reaction [[CYP3A5 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] CTD PMID:34189909 1-hydroxymidazolam increases chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam CTD PMID:18191104 and PMID:26958860 1-naphthol increases abundance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthol increases abundance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthyl isothiocyanate decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP3A9 mRNA CTD PMID:25380136 and PMID:30723492 17alpha-ethynylestradiol increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of CYP3A13 mRNA CTD PMID:17108234 17alpha-ethynylestradiol increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Ethinyl Estradiol CTD PMID:15304426 17beta-estradiol decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP3A7 mRNA CTD PMID:17982697 and PMID:20106945 17beta-estradiol decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of CYP3A9 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP3A9 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP3A9 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [3 more ... CTD PMID:16984957 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2 more ... CTD PMID:21851831 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 2 more ... CTD PMID:20566336 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2 more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CYP3A5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP3A5 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP3A13 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CYP3A7 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP3A7 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP3A13 mRNA CTD PMID:16984957 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP3A13 mRNA and Tetrachlorodibenzodioxin results in decreased expression of CYP3A9 mRNA CTD PMID:16054898 more ... 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of CYP3A13 mRNA CTD PMID:17982090 2,4-D increases expression ISO CYP3A7 (Homo sapiens) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of CYP3A7 protein CTD PMID:8812189 2,4-dinitrotoluene affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CYP3A13 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Butylated Hydroxytoluene results in increased expression of CYP3A9 mRNA CTD PMID:18539377 2,6-dinitrotoluene affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of CYP3A13 mRNA CTD PMID:21346803 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Verapamil results in decreased expression of CYP3A9 mRNA CTD PMID:17973928 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP3A5 protein CTD PMID:15689501 2-hydroxypropanoic acid increases expression ISO CYP3A7 (Homo sapiens) 6480464 Lactic Acid results in increased expression of CYP3A7 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl affects expression ISO CYP3A7 (Homo sapiens) 6480464 3 more ... CTD PMID:21703328 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [3 more ... CTD PMID:16984957 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 co-treated with NAT2] results in increased susceptibility to 2-amino-3-methylimidazo(4 and 5-f)quinoline CTD PMID:7625840 3-methylcholanthrene increases expression ISO CYP3A5 (Homo sapiens) 6480464 Methylcholanthrene results in increased expression of CYP3A5 mRNA CTD PMID:33408298 3-methylcholanthrene multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 AHR protein affects the reaction [Methylcholanthrene results in increased expression of CYP3A5 mRNA] CTD PMID:33408298 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of CYP3A9 mRNA CTD PMID:9441723 4,4'-diaminodiphenylmethane decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of CYP3A9 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP3A13 mRNA CTD PMID:18648102 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 4-hydroxymidazolam multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] and Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] CTD PMID:18191104 4-hydroxymidazolam increases chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam CTD PMID:18191104 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CYP3A7 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of CYP3A5 mRNA] CTD PMID:21095227 5-hydroxydiclofenac multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac CTD PMID:24246759 5-Hydroxythalidomide multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CTD PMID:20443640 5-Hydroxythalidomide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide and CYP3A5 protein results in increased oxidation of and results in increased glutathionylation of 5-hydroxythalidomide CTD PMID:20443640 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO CYP3A7 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP3A7 mRNA CTD PMID:19118567 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO CYP3A5 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP3A5 mRNA CTD PMID:19118567 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CYP3A9 mRNA CTD PMID:19483382 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 NR1I3 protein promotes the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24144921 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases activity ISO CYP3A7 (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24144921 6-propyl-2-thiouracil affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of CYP3A9 mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CYP3A9 mRNA CTD PMID:24780913 and PMID:25825206 6beta-hydroxytestosterone increases chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone CTD PMID:26239802 6beta-hydroxytestosterone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Testosterone] which results in increased chemical synthesis of 6 beta-hydroxytestosterone more ... CTD PMID:26239802 more ... 8-Br-cAMP decreases expression ISO CYP3A7 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP3A7 mRNA CTD PMID:22079614 8-Br-cAMP decreases expression ISO CYP3A5 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP3A5 mRNA CTD PMID:22079614 9-cis-retinoic acid decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of CYP3A7 mRNA CTD PMID:15982314 acetamide decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 acetamide results in decreased expression of CYP3A9 mRNA CTD PMID:31881176 aconitine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Aconitine CTD PMID:21277363 aconitine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of Aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine CTD PMID:21277363 acrylamide increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of CYP3A9 mRNA CTD PMID:15749267 actinomycin D multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A7 mRNA] CTD PMID:24819614 actinomycin D multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A5 mRNA] CTD PMID:24819614 afimoxifene increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of afimoxifene CTD PMID:29285606 afimoxifene decreases activity ISO CYP3A5 (Homo sapiens) 6480464 afimoxifene results in decreased activity of CYP3A5 protein CTD PMID:12419016 afimoxifene multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite CTD PMID:29285606 aflatoxin B1 decreases methylation ISO CYP3A7 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CYP3A7 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP3A5 mRNA CTD PMID:22100608 more ... aflatoxin B1 increases expression ISO CYP3A5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CYP3A5 mRNA CTD PMID:21632981 and PMID:21994236 aflatoxin B1 affects expression ISO CYP3A5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CYP3A5 protein CTD PMID:20106945 aflatoxin B1 increases activity ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased activity of Aflatoxin B1 CTD PMID:15454734 aflatoxin B1 decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Aflatoxin B1 results in decreased expression of CYP3A9 mRNA CTD PMID:33354967 aflatoxin B1 multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 co-treated with NAT1] results in increased susceptibility to Aflatoxin B1 more ... CTD PMID:7625840 aflatoxin B1 increases expression ISO CYP3A7 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CYP3A7 mRNA CTD PMID:21632981 and PMID:21641981 aflatoxin B1 affects expression ISO CYP3A7 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CYP3A7 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP3A7 mRNA CTD PMID:22100608 Aflatoxin G1 increases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased susceptibility to aflatoxin G1 CTD PMID:11189750 aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 alfentanil affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Alfentanil CTD PMID:15557344 alfentanil multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYB5A protein promotes the reaction [CYP3A5 protein affects the metabolism of Alfentanil] more ... CTD PMID:15557344 and PMID:15731592 alfentanil affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Alfentanil CTD PMID:15557344 more ... all-trans-4-oxoretinoic acid decreases expression ISO CYP3A7 (Homo sapiens) 6480464 4-oxoretinoic acid results in decreased expression of CYP3A7 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Tretinoin results in increased expression of CYP3A9 mRNA CTD PMID:24977338 all-trans-retinoic acid affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Tretinoin CTD PMID:16041241 all-trans-retinoic acid decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Tretinoin metabolite results in decreased expression of CYP3A7 mRNA and Tretinoin results in decreased expression of CYP3A7 mRNA CTD PMID:15982314 alpha-tocotrienol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 tocotrienol more ... CTD PMID:31102695 alpha-tocotrienol affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to tocotrienol and alpha CTD PMID:31102695 alprazolam increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Alprazolam CTD PMID:15903124 amiodarone decreases response to substance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amiodarone decreases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amiodarone affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Amiodarone affects the expression of CYP3A9 mRNA CTD PMID:19483382 amitriptyline increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 Amitriptyline results in increased metabolism of CYP3A5 protein CTD PMID:18359012 amlodipine affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene affects the susceptibility to Amlodipine CTD PMID:22149319 ammonium chloride affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP3A9 mRNA CTD PMID:16483693 amodiaquine increases metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 amodiaquine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine CTD PMID:31629065 amodiaquine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 amodiaquine multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine CTD PMID:31629065 antimycin A increases expression ISO CYP3A5 (Homo sapiens) 6480464 Antimycin A results in increased expression of CYP3A5 mRNA CTD PMID:34642769 antirheumatic drug increases expression ISO CYP3A5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of CYP3A5 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO CYP3A7 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A7 mRNA CTD PMID:17851650 Aroclor 1254 increases expression ISO CYP3A5 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A5 mRNA CTD PMID:17851650 arotinoid acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP3A5 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP3A5 mRNA CTD PMID:32525701 atazanavir sulfate multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 atrazine multiple interactions EXP 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of CYP3A13 mRNA] CTD PMID:36216167 atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP3A13 mRNA CTD PMID:36216167 azoxystrobin increases expression ISO CYP3A5 (Homo sapiens) 6480464 azoxystrobin results in increased expression of CYP3A5 mRNA CTD PMID:34642769 beclomethasone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Beclomethasone results in increased expression of CYP3A5 mRNA CTD PMID:12538830 more ... beclomethasone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] more ... CTD PMID:12538830 and PMID:24555085 Benoxacor decreases expression EXP 6480464 benoxacor results in decreased expression of CYP3A13 mRNA CTD PMID:34850242 benzbromarone affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of CYP3A9 mRNA CTD PMID:19483382 benzo[a]pyrene increases methylation ISO CYP3A7 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CYP3A7 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP3A5 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO CYP3A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CYP3A5 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO CYP3A7 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CYP3A7 mRNA CTD PMID:21632981 and PMID:22316170 benzo[a]pyrene decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP3A7 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP3A13 mRNA and Benzo(a)pyrene results in increased expression of CYP3A13 protein CTD PMID:20127859 and PMID:34472326 benzo[a]pyrene diol epoxide I decreases expression ISO CYP3A5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO CYP3A5 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of CYP3A13 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A13 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO CYP3A5 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP3A5 mRNA CTD PMID:33263786 beta-naphthoflavone decreases expression ISO CYP3A7 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP3A7 mRNA CTD PMID:22258563 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP3A13 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP3A9 mRNA CTD PMID:35970509 bis(2-ethylhexyl) phthalate decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP3A5 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP3A9 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CYP3A13 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP3A5 mRNA and bisphenol A results in decreased expression of CYP3A9 mRNA CTD PMID:25181051 more ... bisphenol A increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of bisphenol A CTD PMID:21402134 bisphenol A multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [bisphenol A results in increased activity of NR1I2 protein] which results in increased expression of CYP3A11 mRNA and [NR1I2 gene results in increased susceptibility to bisphenol A] which results in increased expression of CYP3A11 mRNA CTD PMID:24755147 and PMID:29425287 bisphenol A multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis of hydroquinone CTD PMID:21402134 bosentan affects expression ISO CYP3A7 (Homo sapiens) 6480464 Bosentan affects the expression of CYP3A7 mRNA CTD PMID:29761207 bromobenzene decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 bromobenzene results in decreased expression of CYP3A9 mRNA CTD PMID:17538237 budesonide increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Budesonide results in increased expression of CYP3A9 mRNA CTD PMID:19562681 and PMID:20888898 budesonide increases expression ISO CYP3A5 (Homo sapiens) 6480464 Budesonide results in increased expression of CYP3A5 mRNA CTD PMID:12538830 and PMID:24555085 budesonide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA] and Mifepristone inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA] CTD PMID:12538830 and PMID:24555085 bupivacaine multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of CYP3A9 mRNA CTD PMID:22341215 buspirone increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Buspirone results in increased expression of CYP3A9 mRNA CTD PMID:24136188 buspirone increases oxidation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of Buspirone CTD PMID:15640381 butyric acid increases expression ISO CYP3A5 (Homo sapiens) 6480464 Butyric Acid results in increased expression of CYP3A5 mRNA CTD PMID:30439556 cadmium dichloride affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of CYP3A9 mRNA CTD PMID:22110744 cadmium dichloride affects expression ISO CYP3A7 (Homo sapiens) 6480464 Cadmium Chloride affects the expression of CYP3A7 mRNA CTD PMID:26314618 calciol increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Cholecalciferol CTD PMID:16207822 calcitriol increases expression ISO CYP3A7 (Homo sapiens) 6480464 Calcitriol results in increased expression of CYP3A7 mRNA CTD PMID:12040012 and PMID:16002434 calcitriol increases expression ISO CYP3A5 (Homo sapiens) 6480464 Calcitriol results in increased expression of CYP3A5 mRNA CTD PMID:16002434 more ... calcitriol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CYP3A5 mRNA CTD PMID:21592394 cannabidiol decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Cannabidiol results in decreased activity of CYP3A5 protein CTD PMID:24667653 carbamazepine increases expression ISO CYP3A7 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP3A7 mRNA CTD PMID:17112801 carbamazepine increases expression ISO CYP3A5 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP3A5 mRNA CTD PMID:12673034 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 carbosulfan increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of carbosulfan CTD PMID:20307514 carfentanil increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of carfentanil CTD PMID:33652071 carmustine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 CGP 52608 multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP3A7 gene] CTD PMID:28238834 CGP 52608 multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP3A5 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA more ... CTD PMID:33819548 CHIR 99021 multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroethene decreases expression EXP 6480464 Vinyl Chloride results in decreased expression of CYP3A13 mRNA CTD PMID:18579281 chlorpromazine decreases response to substance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpromazine decreases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpyrifos affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Chlorpyrifos CTD PMID:17079358 and PMID:17110060 chlorpyrifos increases expression ISO CYP3A5 (Homo sapiens) 6480464 Chlorpyrifos results in increased expression of CYP3A5 mRNA CTD PMID:16757081 and PMID:33011216 chlorpyrifos affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Chlorpyrifos CTD PMID:17079358 and PMID:17110060 chlorzoxazone affects metabolic processing ISO Cyp3a9 (Rattus norvegicus) 6480464 CYP3A9 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CYP3A13 mRNA CTD PMID:23625948 cisplatin multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CYP3A5 mRNA and CYP3A5 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 and PMID:27392435 citral multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18824010 clobetasol increases expression ISO CYP3A5 (Homo sapiens) 6480464 Clobetasol results in increased expression of CYP3A5 mRNA CTD PMID:16882163 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP3A13 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP3A13 mRNA] CTD PMID:17585979 clofibrate affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Clofibrate affects the expression of CYP3A9 mRNA CTD PMID:19483382 clofibric acid multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP3A13 mRNA CTD PMID:17602206 clopidogrel affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to Clopidogrel CTD PMID:16754899 clopidogrel multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of and results in increased cleavage of Clopidogrel metabolite CTD PMID:19170597 clothianidin increases expression ISO CYP3A5 (Homo sapiens) 6480464 clothianidin results in increased expression of CYP3A5 mRNA CTD PMID:32201337 clothianidin multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein and [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA CTD PMID:32201337 clotrimazole increases expression ISO CYP3A7 (Homo sapiens) 6480464 Clotrimazole results in increased expression of CYP3A7 mRNA CTD PMID:12673034 clotrimazole increases expression ISO CYP3A5 (Homo sapiens) 6480464 Clotrimazole results in increased expression of CYP3A5 protein CTD PMID:8632764 clozapine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Clozapine CTD PMID:18809730 Clozapine N-oxide increases chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased chemical synthesis of clozapine N-oxide CTD PMID:18809730 cobalt dichloride decreases expression ISO CYP3A5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CYP3A5 mRNA CTD PMID:22941251 copper atom increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Copper results in increased expression of CYP3A13 mRNA CTD PMID:22465980 copper(0) increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Copper results in increased expression of CYP3A13 mRNA CTD PMID:22465980 copper(II) sulfate increases expression ISO CYP3A7 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CYP3A7 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO CYP3A5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CYP3A5 mRNA CTD PMID:19549813 corticosterone increases metabolic processing EXP 6480464 Corticosterone results in increased metabolism of CYP3A5 protein CTD PMID:20032461 cortisol increases expression ISO CYP3A5 (Homo sapiens) 6480464 Hydrocortisone results in increased expression of CYP3A5 mRNA CTD PMID:23223499 cortisol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cuprizon decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of CYP3A9 mRNA CTD PMID:27523638 cyazofamid decreases expression ISO CYP3A5 (Homo sapiens) 6480464 cyazofamid results in decreased expression of CYP3A5 mRNA CTD PMID:34642769 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CYP3A13 mRNA CTD PMID:24819615 cyclophosphamide affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to Cyclophosphamide CTD PMID:16087946 cyclophosphamide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 cyclophosphamide affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Cyclophosphamide CTD PMID:16087946 cyclosporin A decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP3A7 mRNA CTD PMID:20106945 more ... cyclosporin A affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Cyclosporine and CYP3A5 protein polymorphism affects the metabolism of Cyclosporine CTD PMID:15450954 more ... cyclosporin A decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP3A5 mRNA CTD PMID:20106945 and PMID:25562108 cyclosporin A multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 cyclosporin A increases expression ISO CYP3A5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CYP3A5 mRNA CTD PMID:12673034 cyclosporin A increases expression ISO CYP3A7 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CYP3A7 mRNA CTD PMID:12673034 cylindrospermopsin decreases expression ISO CYP3A7 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of CYP3A7 mRNA CTD PMID:23726867 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP3A13 mRNA CTD PMID:31659573 cypermethrin multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP3A13 mRNA] CTD PMID:31659573 cyproconazole increases expression ISO CYP3A7 (Homo sapiens) 6480464 cyproconazole results in increased expression of CYP3A7 mRNA CTD PMID:29995386 cyproconazole increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 cyproconazole results in increased expression of CYP3A9 protein CTD PMID:33150952 D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 dabrafenib decreases activity ISO CYP3A5 (Homo sapiens) 6480464 dabrafenib results in decreased activity of CYP3A5 protein CTD PMID:34780725 decabromodiphenyl ether increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased expression of CYP3A9 mRNA CTD PMID:32679240 Dechloroethylcyclophosphamide affects chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the chemical synthesis of dechloroethylcyclophosphamide CTD PMID:15875221 deguelin affects expression ISO CYP3A5 (Homo sapiens) 6480464 deguelin affects the expression of CYP3A5 mRNA CTD PMID:34642769 dehydroepiandrosterone affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Dehydroepiandrosterone CTD PMID:16041241 dehydroepiandrosterone increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Dehydroepiandrosterone CTD PMID:15845858 dehydroepiandrosterone increases hydroxylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased hydroxylation of Dehydroepiandrosterone CTD PMID:15845858 more ... dehydroepiandrosterone sulfate increases hydroxylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased hydroxylation of Dehydroepiandrosterone Sulfate CTD PMID:15985487 dehydroepiandrosterone sulfate multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Ritonavir inhibits the reaction [CYP3A7 protein results in increased oxidation of Dehydroepiandrosterone Sulfate] CTD PMID:33821626 dehydroepiandrosterone sulfate increases oxidation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased oxidation of Dehydroepiandrosterone Sulfate CTD PMID:33821626 dehydroepiandrosterone sulfate affects abundance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 promoter polymorphism affects the abundance of Dehydroepiandrosterone Sulfate CTD PMID:15985487 delta-tocotrienol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 tocotrienol more ... CTD PMID:31102695 delta-tocotrienol affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to tocotrienol and delta CTD PMID:31102695 deoxycholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA more ... CTD PMID:33819548 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP3A13 mRNA CTD PMID:14570766 and PMID:31678242 dexamethasone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CYP3A5 mRNA] and NR3C1 protein affects the reaction [Dexamethasone results in increased expression of CYP3A5 mRNA] CTD PMID:12538830 dexamethasone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CYP3A5 mRNA CTD PMID:10696073 more ... dexamethasone increases expression ISO CYP3A7 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CYP3A7 mRNA CTD PMID:19118567 and PMID:24146111 dexamethasone increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of CYP3A9 mRNA CTD PMID:19562681 and PMID:20888898 dexamethasone multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of CYP3A9 mRNA CTD PMID:22341215 dexamethasone decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of CYP3A9 mRNA CTD PMID:15102944 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A13 mRNA CTD PMID:29950665 dextromethorphan increases oxidation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of Dextromethorphan CTD PMID:15383492 dextromethorphan affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Dextromethorphan CTD PMID:15988119 dextromethorphan decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Dextromethorphan CTD PMID:15383492 dextrorphan affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Dextrorphan CTD PMID:15988119 diazinon increases expression ISO CYP3A5 (Homo sapiens) 6480464 Diazinon results in increased expression of CYP3A5 mRNA CTD PMID:16757081 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP3A13 mRNA CTD PMID:26934552 diclofenac decreases activity EXP 6480464 Diclofenac metabolite results in decreased activity of CYP3A13 protein CTD PMID:28960974 dicrotophos decreases expression ISO CYP3A7 (Homo sapiens) 6480464 dicrotophos results in decreased expression of CYP3A7 mRNA CTD PMID:28302478 dicrotophos decreases expression ISO CYP3A5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of CYP3A5 mRNA CTD PMID:28302478 diltiazem affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Diltiazem and CYP3A5 protein polymorphism affects the metabolism of Diltiazem CTD PMID:16024008 diltiazem decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Diltiazem CTD PMID:15499178 dimethyl sulfoxide affects expression ISO CYP3A7 (Homo sapiens) 6480464 Dimethyl Sulfoxide affects the expression of CYP3A7 mRNA CTD PMID:12843640 dimethyl sulfoxide affects expression ISO CYP3A5 (Homo sapiens) 6480464 Dimethyl Sulfoxide affects the expression of CYP3A5 mRNA CTD PMID:12843640 diosmetin multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] CTD PMID:18191104 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP3A13 mRNA] CTD PMID:31659573 diuron increases expression ISO CYP3A7 (Homo sapiens) 6480464 Diuron results in increased expression of CYP3A7 protein CTD PMID:8812189 Droloxifene decreases activity ISO CYP3A5 (Homo sapiens) 6480464 droloxifene results in decreased activity of CYP3A5 protein CTD PMID:12419016 dronedarone increases metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased metabolism of Dronedarone CTD PMID:29616291 dronedarone increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Dronedarone CTD PMID:29616291 dronedarone decreases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased susceptibility to Dronedarone CTD PMID:29616291 dronedarone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of Dronedarone] which results in increased abundance of N-desbutyldronedarone more ... CTD PMID:29616291 elemental selenium decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Selenium results in decreased expression of CYP3A5 mRNA CTD PMID:19244175 emodin increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Emodin CTD PMID:30672276 endosulfan increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of CYP3A9 mRNA CTD PMID:29391264 endosulfan affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Endosulfan CTD PMID:16581944 enilconazole decreases expression ISO CYP3A7 (Homo sapiens) 6480464 enilconazole results in decreased expression of CYP3A7 mRNA CTD PMID:32201337 enilconazole increases expression ISO CYP3A5 (Homo sapiens) 6480464 enilconazole results in increased expression of CYP3A5 mRNA and enilconazole results in increased expression of CYP3A5 protein CTD PMID:32201337 enilconazole multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein and [enilconazole co-treated with thiacloprid] results in increased expression of CYP3A5 protein CTD PMID:32201337 eplerenone increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Eplerenone CTD PMID:31408697 eplerenone increases abundance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased abundance of Eplerenone metabolite CTD PMID:31408697 erythromycin A decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Erythromycin CTD PMID:15383492 erythromycin estolate increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Erythromycin Estolate results in increased expression of CYP3A9 mRNA CTD PMID:24412560 estriol multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Estriol inhibits the reaction [imidacloprid results in increased expression of CYP3A7] more ... CTD PMID:28750898 estrone increases hydroxylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased hydroxylation of Estrone CTD PMID:15985487 estrone affects abundance ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 promoter polymorphism affects the abundance of Estrone CTD PMID:15985487 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP3A13 mRNA CTD PMID:19167417 ethanol decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Ethanol results in decreased expression of CYP3A7 mRNA CTD PMID:31059573 etoposide decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Etoposide CTD PMID:8114683 etoposide affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to Etoposide CTD PMID:12969965 fenofibrate multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP3A13 mRNA CTD PMID:18253720 fenofibrate increases expression ISO CYP3A7 (Homo sapiens) 6480464 Fenofibrate results in increased expression of CYP3A7 mRNA CTD PMID:19118567 fenpyroximate increases expression ISO CYP3A5 (Homo sapiens) 6480464 fenpyroximate results in increased expression of CYP3A5 mRNA CTD PMID:34642769 fenthion affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Fenthion CTD PMID:17110060 fenthion affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Fenthion CTD PMID:17110060 fimasartan increases oxidation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of fimasartan CTD PMID:29596975 fimasartan increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of fimasartan CTD PMID:29596975 fipronil increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 fipronil results in increased expression of CYP3A9 mRNA CTD PMID:23962444 fipronil increases expression ISO CYP3A5 (Homo sapiens) 6480464 fipronil results in increased expression of CYP3A5 mRNA CTD PMID:17084830 and PMID:27091632 fipronil multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A5 mRNA CTD PMID:27091632 fipronil increases expression ISO CYP3A7 (Homo sapiens) 6480464 fipronil results in increased expression of CYP3A7 mRNA CTD PMID:27091632 fipronil multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A7 mRNA CTD PMID:27091632 flavonol increases expression ISO CYP3A5 (Homo sapiens) 6480464 3-hydroxyflavone results in increased expression of CYP3A5 mRNA CTD PMID:26238175 fluconazole increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Fluconazole results in increased expression of CYP3A13 mRNA CTD PMID:16643972 flunisolide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [flunisolide results in increased expression of CYP3A5 mRNA] CTD PMID:24555085 flunisolide increases expression ISO CYP3A5 (Homo sapiens) 6480464 flunisolide results in increased expression of CYP3A5 mRNA CTD PMID:24555085 flunitrazepam increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Flunitrazepam CTD PMID:15383492 fluoxetine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Fluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] CTD PMID:12584149 fluticasone affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the susceptibility to Fluticasone CTD PMID:20707410 fluticasone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Fluticasone results in increased expression of CYP3A5 mRNA] CTD PMID:24555085 fluticasone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Fluticasone results in increased expression of CYP3A5 mRNA CTD PMID:24555085 fluticasone decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Fluticasone results in decreased activity of CYP3A5 protein CTD PMID:20707410 fluticasone increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Fluticasone CTD PMID:20707410 fluvoxamine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Fluvoxamine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] CTD PMID:12584149 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of CYP3A13 mRNA CTD PMID:25629700 fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 fumonisin B1 decreases expression EXP 6480464 fumonisin B1 results in decreased expression of CYP3A13 mRNA CTD PMID:16221962 gallocatechin multiple interactions EXP 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA CTD PMID:25663641 gamma-hexachlorocyclohexane increases expression ISO CYP3A7 (Homo sapiens) 6480464 Hexachlorocyclohexane results in increased expression of CYP3A7 protein CTD PMID:8812189 gefitinib affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Gefitinib CTD PMID:15788367 Gelsemine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of gelsemine CTD PMID:34627953 genistein multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CYP3A9 mRNA CTD PMID:21782745 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CYP3A13 mRNA CTD PMID:32186404 geranial multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18824010 geraniol increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of geraniol CTD PMID:18824010 geraniol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18824010 glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 glutathione multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac more ... CTD PMID:24246759 and PMID:26302866 glycochenodeoxycholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA more ... CTD PMID:33819548 haloperidol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol more ... CTD PMID:12584149 helenalin decreases activity ISO CYP3A5 (Homo sapiens) 6480464 helenalin results in decreased activity of CYP3A5 protein CTD PMID:34989853 helenalin increases oxidation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased oxidation of helenalin CTD PMID:34989853 helenalin increases oxidation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of helenalin CTD PMID:34989853 Heliotrine decreases expression ISO CYP3A7 (Homo sapiens) 6480464 heliotrine results in decreased expression of CYP3A7 mRNA CTD PMID:26100227 Heliotrine decreases expression ISO CYP3A5 (Homo sapiens) 6480464 heliotrine results in decreased expression of CYP3A5 mRNA CTD PMID:26100227 Hexachloro-1,3-butadiene increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of hexachlorobutadiene CTD PMID:8555406 hydroquinone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis of hydroquinone CTD PMID:21402134 Hypaconitine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of hypaconitine CTD PMID:21550385 hyperforin increases expression ISO CYP3A5 (Homo sapiens) 6480464 hyperforin results in increased expression of CYP3A5 mRNA CTD PMID:24259679 Icaritin increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of icaritin CTD PMID:30938510 ifosfamide affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Ifosfamide CTD PMID:15875221 ifosfamide decreases ethylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased ethylation of Ifosfamide CTD PMID:15821045 imidacloprid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Estriol inhibits the reaction [imidacloprid results in increased expression of CYP3A7] CTD PMID:28750898 imidacloprid increases expression ISO CYP3A7 (Homo sapiens) 6480464 imidacloprid results in increased expression of CYP3A7 CTD PMID:28750898 indole-3-methanol affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of CYP3A9 mRNA CTD PMID:21396975 indometacin increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of CYP3A9 mRNA CTD PMID:18299717 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP3A13 mRNA CTD PMID:36331819 irinotecan multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [selenomethylselenocysteine co-treated with Irinotecan] results in increased expression of CYP3A5 CTD PMID:15897249 isotretinoin decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of CYP3A7 mRNA CTD PMID:15982314 ketoconazole multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus] more ... CTD PMID:15731592 more ... ketoconazole decreases activity ISO CYP3A7 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP3A7 protein CTD PMID:37788138 ketoconazole affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to Ketoconazole CTD PMID:31102695 ketoconazole decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP3A5 protein CTD PMID:15557344 more ... L-ascorbic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA CTD PMID:34480604 L-ethionine affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Ethionine affects the expression of CYP3A9 mRNA CTD PMID:19483382 lansoprazole multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole] CTD PMID:17377957 lapatinib increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Lapatinib CTD PMID:26958860 and PMID:37788138 lapatinib increases metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased metabolism of Lapatinib CTD PMID:37788138 lapatinib multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein inhibits the reaction [Lapatinib results in increased expression of H2AX protein] CTD PMID:37788138 lapatinib multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of Lapatinib] which results in increased activity of NFE2L2 protein and CYP3A5 protein inhibits the reaction [Lapatinib results in increased expression of H2AX protein] CTD PMID:26958860 and PMID:37788138 Lasiocarpine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of lasiocarpine CTD PMID:31103741 lead diacetate increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 lead acetate results in increased expression of CYP3A9 mRNA CTD PMID:22641619 lidocaine decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Lidocaine CTD PMID:15383492 lipopolysaccharide increases expression ISO CYP3A5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of CYP3A5 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 lithocholic acid increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Lithocholic Acid results in increased expression of CYP3A9 mRNA CTD PMID:20888898 lithocholic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased oxidation of Lithocholic Acid] which results in increased chemical synthesis of 3-ketocholanoic acid more ... CTD PMID:31102695 lithocholic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [Lithocholic Acid results in increased activity of NR1I2 protein] which results in increased expression of CYP3A11 mRNA CTD PMID:14570758 lithocholic acid increases oxidation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of Lithocholic Acid CTD PMID:31102695 luteolin multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] CTD PMID:18191104 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of CYP3A13 mRNA] CTD PMID:36216167 malathion affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Malathion CTD PMID:17110060 malathion increases expression ISO CYP3A5 (Homo sapiens) 6480464 Malathion results in increased expression of CYP3A5 mRNA CTD PMID:37047231 malathion increases expression ISO CYP3A7 (Homo sapiens) 6480464 Malathion results in increased expression of CYP3A7 mRNA CTD PMID:37047231 malathion affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Malathion CTD PMID:17110060 Meclizine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Meclizine inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone] and Meclizine inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone] CTD PMID:26239802 Meclizine multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP3A11 mRNA] CTD PMID:15272053 MeIQ multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 co-treated with NAT2] results in increased susceptibility to 2-amino-3 more ... CTD PMID:7625840 MeIQx multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 co-treated with NAT2] results in increased susceptibility to 2-amino-3 more ... CTD PMID:7625840 mercury dichloride increases expression ISO CYP3A5 (Homo sapiens) 6480464 Mercuric Chloride results in increased expression of CYP3A5 mRNA CTD PMID:37172713 methoxychlor decreases methylation ISO Cyp3a9 (Rattus norvegicus) 6480464 CYP3A5 protein results in decreased methylation of Methoxychlor CTD PMID:12433799 methoxychlor increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of CYP3A9 mRNA CTD PMID:21782745 methoxychlor multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CYP3A9 mRNA CTD PMID:21782745 midazolam affects metabolic processing ISO Cyp3a9 (Rattus norvegicus) 6480464 CYP3A5 protein affects the metabolism of Midazolam CTD PMID:15801540 midazolam increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Midazolam CTD PMID:26958860 midazolam affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the metabolism of Midazolam and CYP3A5 protein affects the metabolism of Midazolam CTD PMID:15801540 more ... midazolam increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Midazolam CTD PMID:15383492 more ... midazolam multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam more ... CTD PMID:19557931 and PMID:34189909 mifepristone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] more ... CTD PMID:12538830 monocrotaline increases expression ISO CYP3A7 (Homo sapiens) 6480464 Monocrotaline results in increased expression of CYP3A7 mRNA CTD PMID:32682830 monosodium L-glutamate decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Sodium Glutamate results in decreased expression of CYP3A9 mRNA CTD PMID:20928830 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA and [Sodium Glutamate co-treated with Tea] affects the expression of CYP3A13 mRNA CTD PMID:25663641 mycophenolic acid increases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased methylation of Mycophenolic Acid CTD PMID:15570183 N,N-diethyl-m-toluamide multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A7 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of DEET CTD PMID:11854147 N,N-diethyl-m-toluamide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A5 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide increases expression ISO CYP3A5 (Homo sapiens) 6480464 DEET results in increased expression of CYP3A5 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide increases expression ISO CYP3A7 (Homo sapiens) 6480464 DEET results in increased expression of CYP3A7 mRNA CTD PMID:27091632 N-desmethylclozapine increases chemical synthesis ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 N-Desmethyltamoxifen multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 N-Desmethyltamoxifen decreases activity ISO CYP3A5 (Homo sapiens) 6480464 N-desmethyltamoxifen results in decreased activity of CYP3A5 protein CTD PMID:12419016 N-Desmethyltamoxifen increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of N-desmethyltamoxifen CTD PMID:29285606 N-methyl-4-phenylpyridinium increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CYP3A9 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP3A13 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A13 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of CYP3A13 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP3A13 mRNA] CTD PMID:17942915 N-nitrosodimethylamine decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of CYP3A9 mRNA CTD PMID:25380136 N-nitrosodimethylamine increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CYP3A13 mRNA CTD PMID:17072980 N-Vinyl-2-pyrrolidone multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP3A9 mRNA CTD PMID:22037397 naphthalene increases expression ISO CYP3A5 (Homo sapiens) 6480464 naphthalene results in increased expression of CYP3A5 mRNA CTD PMID:20500019 nefazodone increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 nefazodone results in increased expression of CYP3A9 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 nefazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] CTD PMID:12584149 nelfinavir decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Nelfinavir results in decreased activity of CYP3A5 protein CTD PMID:15523003 nevirapine increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Nevirapine results in increased expression of CYP3A9 mRNA CTD PMID:23947594 nickel atom decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Nickel results in decreased expression of CYP3A5 mRNA CTD PMID:24768652 and PMID:25583101 nimesulide increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 nimesulide results in increased expression of CYP3A9 mRNA CTD PMID:24136188 Norfluoxetine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 norfluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] CTD PMID:12584149 nortriptyline increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 Nortriptyline results in increased metabolism of CYP3A5 protein CTD PMID:18359012 norverapamil decreases activity ISO CYP3A5 (Homo sapiens) 6480464 norverapamil results in decreased activity of CYP3A5 protein CTD PMID:15689501 O-methyleugenol decreases expression ISO CYP3A7 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP3A7 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO CYP3A7 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP3A7 mRNA CTD PMID:27939613 obeticholic acid decreases expression ISO CYP3A5 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP3A5 mRNA CTD PMID:27939613 ochratoxin A increases expression ISO CYP3A5 (Homo sapiens) 6480464 ochratoxin A results in increased expression of CYP3A5 mRNA CTD PMID:21834667 ochratoxin A decreases expression ISO CYP3A5 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of CYP3A5 mRNA CTD PMID:26505656 ochratoxin A increases response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased susceptibility to ochratoxin A CTD PMID:11189750 okadaic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of and results in increased hydroxylation of and results in decreased susceptibility to Okadaic Acid CTD PMID:26374342 omeprazole affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CYP3A9 mRNA CTD PMID:19483382 omeprazole increases expression ISO CYP3A5 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP3A5 mRNA CTD PMID:19118567 omeprazole increases expression ISO CYP3A7 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP3A7 mRNA CTD PMID:19118567 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CYP3A13 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CYP3A13 mRNA CTD PMID:34911549 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP3A13 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP3A13 mRNA] CTD PMID:17585979 paracetamol increases expression ISO CYP3A5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CYP3A5 mRNA CTD PMID:26497421 paracetamol increases activity EXP 6480464 Acetaminophen results in increased activity of CYP3A5 protein CTD PMID:35948136 paracetamol decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP3A5 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 paracetamol decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP3A7 mRNA CTD PMID:26497421 and PMID:29067470 paracetamol increases expression ISO CYP3A7 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CYP3A7 mRNA CTD PMID:22230336 paracetamol affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CYP3A13 mRNA CTD PMID:17366322 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP3A13 mRNA CTD PMID:17562736 paraoxon multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Paraoxon inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] CTD PMID:24555085 parathion increases expression ISO CYP3A7 (Homo sapiens) 6480464 Parathion results in increased expression of CYP3A7 mRNA CTD PMID:17982697 parathion affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Parathion CTD PMID:12669189 more ... parathion affects metabolic processing ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein affects the metabolism of Parathion CTD PMID:17079358 and PMID:17110060 PD 0325901 increases expression ISO CYP3A7 (Homo sapiens) 6480464 mirdametinib results in increased expression of CYP3A7 mRNA CTD PMID:24819614 PD 0325901 increases expression ISO CYP3A5 (Homo sapiens) 6480464 mirdametinib results in increased expression of CYP3A5 mRNA CTD PMID:24819614 pentachlorophenol increases expression ISO CYP3A7 (Homo sapiens) 6480464 Pentachlorophenol results in increased expression of CYP3A7 protein CTD PMID:8812189 perfluorohexanesulfonic acid increases expression ISO CYP3A5 (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in increased expression of CYP3A5 mRNA CTD PMID:23567314 perfluorohexanesulfonic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [perfluorohexanesulfonic acid binds to CYP3A7 protein] which results in decreased activity of CYP3A7 protein CTD PMID:36638633 perfluorononanoic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [perfluoro-n-nonanoic acid binds to CYP3A7 protein] which results in decreased activity of CYP3A7 protein CTD PMID:36638633 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP3A13 mRNA CTD PMID:20936131 perfluorooctane-1-sulfonic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [perfluorooctane sulfonic acid binds to CYP3A7 protein] which results in decreased activity of CYP3A7 protein CTD PMID:36638633 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP3A13 mRNA more ... CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO CYP3A5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP3A5 mRNA CTD PMID:27153767 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP3A13 mRNA CTD PMID:25949234 perfluorooctanoic acid increases expression ISO CYP3A7 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP3A7 mRNA CTD PMID:37302725 perfluorooctanoic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [perfluorooctanoic acid binds to CYP3A7 protein] which results in decreased activity of CYP3A7 protein CTD PMID:36638633 perfluorooctanoic acid increases expression ISO CYP3A5 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP3A5 mRNA CTD PMID:37302725 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP3A13 mRNA CTD PMID:18281256 permethrin increases expression ISO CYP3A5 (Homo sapiens) 6480464 Permethrin results in increased expression of CYP3A5 mRNA CTD PMID:19326768 phencyclidine affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Phencyclidine CTD PMID:16782764 phenethyl isothiocyanate decreases expression ISO CYP3A5 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of CYP3A5 mRNA CTD PMID:20442190 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP3A13 mRNA CTD PMID:19270015 and PMID:19850644 phenobarbital multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP3A11 mRNA and Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP3A11 mRNA] CTD PMID:15272053 phenobarbital increases expression ISO CYP3A5 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP3A5 mRNA and Phenobarbital results in increased expression of CYP3A5 protein CTD PMID:10696073 more ... phenobarbital affects expression ISO CYP3A5 (Homo sapiens) 6480464 Phenobarbital affects the expression of CYP3A5 mRNA CTD PMID:19159669 phenobarbital affects expression ISO CYP3A7 (Homo sapiens) 6480464 Phenobarbital affects the expression of CYP3A7 mRNA CTD PMID:19159669 phenobarbital increases expression ISO CYP3A7 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP3A11 protein more ... CTD PMID:19084549 more ... phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP3A13 mRNA CTD PMID:23091169 phenobarbital increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP3A9 mRNA CTD PMID:19162173 more ... phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP3A13 mRNA CTD PMID:19903449 phenytoin increases expression ISO CYP3A5 (Homo sapiens) 6480464 Phenytoin results in increased expression of CYP3A5 mRNA CTD PMID:12673034 phenytoin increases expression ISO CYP3A7 (Homo sapiens) 6480464 Phenytoin results in increased expression of CYP3A7 mRNA CTD PMID:12673034 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of CYP3A7 mRNA CTD PMID:22538082 phlorizin increases expression EXP 6480464 Phlorhizin results in increased expression of CYP3A7 mRNA CTD PMID:22538082 physostigmine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Physostigmine inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] CTD PMID:24555085 picoxystrobin affects expression ISO CYP3A5 (Homo sapiens) 6480464 picoxystrobin affects the expression of CYP3A5 mRNA CTD PMID:34642769 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP3A13 mRNA CTD PMID:19850644 pirinixic acid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP3A5 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP3A7 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of CYP3A9 mRNA CTD PMID:19162173 more ... pirinixic acid affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of CYP3A9 mRNA CTD PMID:19483382 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP3A13 mRNA CTD PMID:18445702 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP3A13 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A9 mRNA CTD PMID:15596064 more ... pregnenolone 16alpha-carbonitrile increases expression ISO CYP3A7 (Homo sapiens) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA CTD PMID:26883953 pregnenolone 16alpha-carbonitrile multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA] CTD PMID:26883953 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A13 mRNA CTD PMID:28903501 prochloraz increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 prochloraz results in increased expression of CYP3A9 protein CTD PMID:33150952 progesterone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP3A5 mRNA CTD PMID:22837389 pyrazinecarboxamide decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Pyrazinamide results in decreased expression of CYP3A9 mRNA CTD PMID:22431067 quercetin affects expression EXP 6480464 Quercetin affects the expression of CYP3A13 mRNA CTD PMID:19270413 quercetin increases expression ISO CYP3A5 (Homo sapiens) 6480464 Quercetin results in increased expression of CYP3A5 mRNA CTD PMID:26238175 quercetin decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Quercetin results in decreased expression of CYP3A5 mRNA CTD PMID:21632981 quinacrine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Quinacrine CTD PMID:16581945 rabeprazole multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole] CTD PMID:17377957 rac-lactic acid increases expression ISO CYP3A7 (Homo sapiens) 6480464 Lactic Acid results in increased expression of CYP3A7 mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein promotes the reaction [tetrandrine results in increased abundance of Reactive Oxygen Species] CTD PMID:26302866 Rebamipide increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 rebamipide results in increased expression of CYP3A9 mRNA CTD PMID:18299717 reserpine increases expression ISO CYP3A5 (Homo sapiens) 6480464 Reserpine results in increased expression of CYP3A5 protein CTD PMID:8632764 riddelliine increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 riddelliine results in increased expression of CYP3A9 mRNA CTD PMID:18047727 rifampicin increases expression ISO CYP3A7 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP3A7 mRNA CTD PMID:12673034 more ... rifampicin increases expression ISO CYP3A5 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP3A5 mRNA CTD PMID:12040753 more ... rifaximin multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [NR1I2 results in increased susceptibility to Rifaximin] which results in increased expression of CYP3A11 mRNA CTD PMID:22790967 risperidone affects abundance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the abundance of Risperidone and CYP3A5 protein affects the abundance of Risperidone CTD PMID:20332423 risperidone increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Risperidone CTD PMID:18708991 ritonavir multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Ritonavir inhibits the reaction [CYP3A7 protein results in increased oxidation of Dehydroepiandrosterone Sulfate] CTD PMID:33821626 ritonavir decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Ritonavir results in decreased activity of CYP3A5 protein CTD PMID:15523003 rivaroxaban increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Rivaroxaban CTD PMID:34189909 rivaroxaban multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 erdafitinib inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Rivaroxaban] CTD PMID:34189909 romidepsin affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of romidepsin CTD PMID:15635176 rotenone decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Rotenone results in decreased expression of CYP3A7 mRNA CTD PMID:29955902 rotenone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Rotenone results in increased expression of CYP3A5 mRNA CTD PMID:34642769 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Salinomycin increases expression ISO CYP3A5 (Homo sapiens) 6480464 salinomycin results in increased expression of CYP3A5 mRNA CTD PMID:34806536 SB 431542 multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of CYP3A5 mRNA CTD PMID:34480604 Se-methyl-L-selenocysteine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [selenomethylselenocysteine co-treated with Irinotecan] results in increased expression of CYP3A5 CTD PMID:15897249 Se-methylselenocysteine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [selenomethylselenocysteine co-treated with Irinotecan] results in increased expression of CYP3A5 CTD PMID:15897249 selenium atom decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Selenium results in decreased expression of CYP3A5 mRNA CTD PMID:19244175 senecionine increases expression ISO CYP3A7 (Homo sapiens) 6480464 senecionine results in increased expression of CYP3A7 mRNA CTD PMID:26100227 senecionine decreases expression ISO CYP3A5 (Homo sapiens) 6480464 senecionine results in decreased expression of CYP3A5 mRNA CTD PMID:26100227 Senkirkine decreases expression ISO CYP3A5 (Homo sapiens) 6480464 senkirkine results in decreased expression of CYP3A5 mRNA CTD PMID:26100227 silicon dioxide decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP3A7 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP3A5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO CYP3A5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CYP3A5 mRNA CTD PMID:23806026 simvastatin affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 polymorphism affects the susceptibility to Simvastatin CTD PMID:17192506 sodium arsenate multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP3A5 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO CYP3A7 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP3A7 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO CYP3A5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP3A5 mRNA CTD PMID:29301061 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP3A13 mRNA and sodium arsenite results in decreased expression of CYP3A5 mRNA CTD PMID:11353140 and PMID:31532247 sodium dichromate decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 sodium bichromate results in decreased expression of CYP3A9 mRNA CTD PMID:25993096 sorafenib affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein polymorphism affects the metabolism of Sorafenib CTD PMID:35099304 sulfaphenazole multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Sulfaphenazole inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone] CTD PMID:31102695 tacrolimus hydrate decreases methylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in decreased methylation of Tacrolimus CTD PMID:15951320 tacrolimus hydrate decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Tacrolimus CTD PMID:15951320 tacrolimus hydrate multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole] more ... CTD PMID:17377957 and PMID:19384264 tacrolimus hydrate affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene affects the susceptibility to Tacrolimus and CYP3A5 polymorphism affects the susceptibility to Tacrolimus CTD PMID:15723604 and PMID:36931438 tacrolimus hydrate affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the metabolism of Tacrolimus more ... CTD PMID:15502717 more ... tamarixetin increases expression ISO CYP3A5 (Homo sapiens) 6480464 tamarixetin results in increased expression of CYP3A5 mRNA CTD PMID:26238175 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP3A13 mRNA CTD PMID:25123088 tamoxifen increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Tamoxifen CTD PMID:29285606 tamoxifen decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Tamoxifen results in decreased activity of CYP3A5 protein CTD PMID:12419016 tamoxifen affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Tamoxifen and CYP3A5 protein polymorphism affects the metabolism of Tamoxifen CTD PMID:15596297 tamoxifen multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased metabolism of Tamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 tanespimycin affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of tanespimycin CTD PMID:15718306 tartrazine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 tebuconazole increases expression ISO CYP3A7 (Homo sapiens) 6480464 tebuconazole results in increased expression of CYP3A7 mRNA CTD PMID:30458266 tebufenpyrad increases expression ISO CYP3A5 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of CYP3A5 mRNA CTD PMID:34642769 teniposide decreases methylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in decreased methylation of Teniposide CTD PMID:8114683 Terfenadine affects metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the metabolism of Terfenadine CTD PMID:15383492 testosterone affects metabolic processing ISO Cyp3a9 (Rattus norvegicus) 6480464 CYP3A9 protein affects the metabolism of Testosterone CTD PMID:15879494 testosterone multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP3A9 mRNA CTD PMID:32741896 testosterone increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Testosterone CTD PMID:15383492 more ... testosterone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Testosterone] which results in increased chemical synthesis of 6 beta-hydroxytestosterone more ... CTD PMID:21592394 more ... testosterone decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Testosterone results in decreased expression of CYP3A5 mRNA CTD PMID:33359661 testosterone increases expression ISO CYP3A5 (Homo sapiens) 6480464 Testosterone results in increased expression of CYP3A5 mRNA CTD PMID:21592394 testosterone increases hydroxylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased hydroxylation of Testosterone CTD PMID:15845858 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of CYP3A13 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP3A13 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP3A9 mRNA CTD PMID:31150632 tetrodotoxin multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of CYP3A9 mRNA CTD PMID:22341215 thalidomide increases hydroxylation ISO CYP3A7 (Homo sapiens) 6480464 CYP3A7 protein results in increased hydroxylation of Thalidomide CTD PMID:20443640 thalidomide increases hydroxylation ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased hydroxylation of Thalidomide CTD PMID:20443640 thalidomide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CTD PMID:20443640 thalidomide increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Thalidomide CTD PMID:28745489 thalidomide increases expression ISO CYP3A5 (Homo sapiens) 6480464 Thalidomide results in increased expression of CYP3A5 mRNA CTD PMID:28496040 thalidomide multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 [CYP3A7 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CTD PMID:20443640 thiacloprid increases expression ISO CYP3A7 (Homo sapiens) 6480464 thiacloprid results in increased expression of CYP3A7 and thiacloprid results in increased expression of CYP3A7 mRNA CTD PMID:28750898 and PMID:32201337 thiacloprid increases expression ISO CYP3A5 (Homo sapiens) 6480464 thiacloprid results in increased expression of CYP3A5 mRNA CTD PMID:32201337 thiacloprid multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [enilconazole co-treated with thiacloprid] results in increased expression of CYP3A5 protein and [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA CTD PMID:32201337 thiacloprid multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Estriol inhibits the reaction [thiacloprid results in increased expression of CYP3A7] CTD PMID:28750898 thiamethoxam increases expression ISO CYP3A7 (Homo sapiens) 6480464 Thiamethoxam results in increased expression of CYP3A7 CTD PMID:28750898 thiamethoxam multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 Estriol inhibits the reaction [Thiamethoxam results in increased expression of CYP3A7] CTD PMID:28750898 thioacetamide affects expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of CYP3A9 mRNA CTD PMID:19483382 thioacetamide multiple interactions ISO Cyp3a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A13 mRNA CTD PMID:28943392 thioacetamide decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP3A9 mRNA CTD PMID:23411599 and PMID:34492290 Thiotepa affects export ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene SNP affects the export of Thiotepa CTD PMID:19076156 Thiotepa affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the susceptibility to Thiotepa CTD PMID:19076156 ticlopidine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite CTD PMID:19170597 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A13 mRNA CTD PMID:29950665 trabectedin decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 trabectedin results in decreased expression of CYP3A13 mRNA CTD PMID:12154027 trazodone multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Trazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol] CTD PMID:12584149 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP3A13 mRNA CTD PMID:19010342 triamcinolone acetonide increases expression ISO CYP3A5 (Homo sapiens) 6480464 Triamcinolone Acetonide results in increased expression of CYP3A5 mRNA CTD PMID:24555085 triamcinolone acetonide multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Triamcinolone Acetonide results in increased expression of CYP3A5 mRNA] CTD PMID:24555085 trichostatin A multiple interactions ISO CYP3A7 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA] CTD PMID:26883953 triclosan increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Triclosan results in increased expression of CYP3A9 mRNA CTD PMID:22659317 triclosan increases expression ISO CYP3A5 (Homo sapiens) 6480464 Triclosan results in increased expression of CYP3A5 mRNA CTD PMID:29849464 triptonide increases expression EXP 6480464 triptonide results in increased expression of CYP3A13 mRNA CTD PMID:33045310 Tris(1-aziridinyl)phosphine oxide affects export ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene SNP affects the export of Triethylenephosphoramide CTD PMID:19076156 Tris(1-aziridinyl)phosphine oxide affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein affects the susceptibility to Triethylenephosphoramide CTD PMID:19076156 troglitazone decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Troglitazone results in decreased expression of CYP3A7 CTD PMID:15618651 troglitazone decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Troglitazone results in decreased expression of CYP3A5 CTD PMID:15618651 troglitazone increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Troglitazone CTD PMID:19356091 troleandomycin decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Troleandomycin results in decreased activity of CYP3A5 protein CTD PMID:15557344 troleandomycin multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 Troleandomycin inhibits the reaction [CYP3A5 protein affects the metabolism of Alfentanil] CTD PMID:15731592 undecane decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 undecane results in decreased expression of CYP3A13 protein CTD PMID:17337753 urethane decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Urethane results in decreased expression of CYP3A7 mRNA CTD PMID:28818685 valdecoxib increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of CYP3A9 mRNA CTD PMID:24136188 valproic acid decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP3A7 mRNA CTD PMID:29154799 valproic acid decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP3A5 mRNA CTD PMID:29154799 valsartan affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene affects the susceptibility to Valsartan CTD PMID:22149319 vanadyl sulfate increases expression ISO CYP3A7 (Homo sapiens) 6480464 vanadyl sulfate results in increased expression of CYP3A7 mRNA CTD PMID:16330358 verapamil decreases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Verapamil results in decreased expression of CYP3A9 mRNA CTD PMID:17973928 verapamil decreases activity ISO CYP3A5 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP3A5 protein CTD PMID:15689501 vincristine multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [CYP3A5 gene polymorphism results in increased activity of CYP3A5 protein] which results in increased metabolism of Vincristine CTD PMID:21225912 vincristine increases metabolic processing ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 protein results in increased metabolism of Vincristine CTD PMID:21225912 vitamin E decreases expression ISO CYP3A7 (Homo sapiens) 6480464 Vitamin E results in decreased expression of CYP3A7 mRNA CTD PMID:19244175 vitamin E decreases expression ISO CYP3A5 (Homo sapiens) 6480464 Vitamin E results in decreased expression of CYP3A5 mRNA CTD PMID:19244175 warfarin affects response to substance ISO CYP3A5 (Homo sapiens) 6480464 CYP3A5 gene polymorphism affects the susceptibility to Warfarin more ... CTD PMID:19752777 and PMID:34382722 XAV939 multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA CTD PMID:34480604 zinc atom increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of CYP3A9 mRNA CTD PMID:11705462 zinc atom multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CYP3A5 mRNA CTD PMID:18593933 zinc(0) increases expression ISO Cyp3a9 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of CYP3A9 mRNA CTD PMID:11705462 zinc(0) multiple interactions ISO CYP3A5 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CYP3A5 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO CYP3A7 (Homo sapiens) 6480464 Zoledronic Acid results in increased expression of CYP3A7 mRNA CTD PMID:24714768 zoledronic acid increases expression ISO CYP3A5 (Homo sapiens) 6480464 Zoledronic Acid results in increased expression of CYP3A5 mRNA CTD PMID:24714768
